drugset / Trial / NCT00644943

A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amoxicillin/Clavulanate in Pediatric Subjects With Acute Otitis Media

NCT00644943

Phase 4 Completed 425 enrolled Abbott
RandomizedSingle-blindTreatment

Summary

The primary objective is to compare the safety and efficacy of cefdinir oral suspension, 7 mg/kg/day ql2hrs for 5 days, to amoxicillin/clavulanate oral suspension 45 mg/kg/day (based on amoxicillin component), in divided doses, q12h for 10 days, in children between 6 months and 6 years of age, with AOM.

Timeline

Start
2003-02
Primary completion
2003-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 45 mg/kg Oral
Comparator cefdinir Other / unclassified 7 mg/kg Oral

Indications